Source:http://linkedlifedata.com/resource/pubmed/id/19760762
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-2-10
|
pubmed:abstractText |
The atypical squamous cell to squamous intraepithelial lesion (ASC/SIL) ratio for cytotechnologists (CTs) may correlate with screening sensitivity in some laboratory settings. Whether this ratio can be applied to other laboratory settings is not known. We conducted a survey of nine cytology laboratories and correlated the ASC/SIL ratio of individual CTs with other laboratory characteristics. The ASC/SIL ratio for individual CTs varied from 0.6 to 4.5 (mean: 1.9, median: 1.5). The ASC/SIL ratio within individual laboratories varied up to 567%; 25/78 (32%) CTs had an ASC/SIL ratio of less than 1.5, though only three of nine laboratories had more than one CT with a ratio this low. Laboratories that used 100% location guided screening (ThinPrep Imaging System) were much less likely to have a CT with a ratio <1.5 (1/20, 5%) than laboratories that never used location guided screening (14/34, 42%; P = 0.004). In addition, the normalized variance of these same laboratories that used location guided screening was significantly lower than those that did not (normalized standard deviation 0.32 vs. 0.55, P = 0.004). The ASC/SIL ratios did not correlate with laboratory volume, individual workload, or type of specimen preparation (conventional vs. liquid based). The ASC/SIL ratio for CTs varies widely between and within laboratories, and may correlate with the use of location guided screening. Very low ASC/SIL ratios are unusual, and CTs with low ratios may warrant further evaluation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1097-0339
|
pubmed:author |
pubmed-author:AugerManonM,
pubmed-author:BirdsongGeorgeG,
pubmed-author:CibasEdmund SES,
pubmed-author:ElsheikhTarik MTM,
pubmed-author:HenryMichaelM,
pubmed-author:HughesJonathan HJH,
pubmed-author:MoriartyAnnA,
pubmed-author:RenshawAndrew AAA,
pubmed-author:TenchWilliamW,
pubmed-author:WilburDavid CDC
|
pubmed:issnType |
Electronic
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
180-3
|
pubmed:meshHeading |
pubmed-meshheading:19760762-Allied Health Personnel,
pubmed-meshheading:19760762-Female,
pubmed-meshheading:19760762-Humans,
pubmed-meshheading:19760762-Mass Screening,
pubmed-meshheading:19760762-Pathology, Clinical,
pubmed-meshheading:19760762-Quality Assurance, Health Care,
pubmed-meshheading:19760762-Reproducibility of Results,
pubmed-meshheading:19760762-Sensitivity and Specificity,
pubmed-meshheading:19760762-Tumor Markers, Biological,
pubmed-meshheading:19760762-Uterine Cervical Neoplasms,
pubmed-meshheading:19760762-Vaginal Smears
|
pubmed:year |
2010
|
pubmed:articleTitle |
ASC/SIL ratio for cytotechnologists: A survey of its utility in clinical practice.
|
pubmed:affiliation |
Department of Pathology, Baptist Hospital of Miami, Miami, Florida 33176, USA. andrewr@baptisthealth.net
|
pubmed:publicationType |
Journal Article
|